EGFR Mutation Detection Kit (Based on real-time PAP nucleic acid amplification)

Up to 60% of non-small cell lung cancer patients harbor somatic EGFR mutations, particularly in non-smokers, females and Asians. The therapy effectiveness of Iressa, Tarceva, Erbitux and Vectibix is closely associated with the mutation status of the EGFR gene that encodes a tyrosine kinase receptor protein.  

Learn More